Galmed Pharmaceuticals Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Galmed Pharmaceuticals Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2023.
  • Galmed Pharmaceuticals Ltd. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $42K, a 81.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42K -$181K -81.2% Dec 31, 2023 6-K 2024-08-28
Q2 2023 $129K -$186K -59% Jun 30, 2023 6-K 2023-08-09
Q4 2022 $223K -$183K -45.1% Dec 31, 2022 20-F 2024-04-04
Q2 2022 $315K -$182K -36.6% Jun 30, 2022 6-K 2022-08-04
Q4 2021 $406K +$12K +3.05% Dec 31, 2021 20-F 2023-03-29
Q2 2021 $497K +$16K +3.33% Jun 30, 2021 6-K 2021-08-05
Q4 2020 $394K -$144K -26.8% Dec 31, 2020 20-F 2022-05-02
Q2 2020 $481K -$122K -20.2% Jun 30, 2020 6-K 2020-08-06
Q4 2019 $538K +$538K Dec 31, 2019 20-F 2021-03-18
Q2 2019 $603K Jun 30, 2019 6-K 2019-08-05
Q4 2018 $0 Dec 31, 2018 20-F 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.